Why the study?
The efficacy and tolerability of small dose intravenous urapidil in the treatment of severe congestive heart failure were not well established.
RCT (n=30)
Open-label
Randomly assigned
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
A 2005 study conducted an RCT in Severe (NYHA class IV) congestive heart failure (n=30). Urapidil vs. Nitroglycerin (20 µg/min intravenously) was evaluated on Efficacy (heart rate, blood pressure, blood gas, and echocardiography parameters).
Synapse has enriched 10 related papers. Consider them for comparative context: